The present application provides compounds of Formula (I):
or pharmaceutically acceptable salts thereof, wherein D is a residue of a GLP-polypeptide or an analog thereof, which underdo hydrolysis under physiological conditions to release the GLP-polypeptide or analog thereof and which are useful in the treatment of disorders that could be beneficially treated with the GLP-polypeptide or analog thereof.
本申请提供了式 (I) 化合物:
或其药学上可接受的盐,其中 D 是 GLP
多肽或其类似物的残基,在生理条件下可
水解释放出 GLP
多肽或其类似物,可用于治疗可使用 GLP
多肽或其类似物进行有益治疗的疾病。